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We and others previously demonstrated that human SVCT1 is a Na ϩ -dependent transporter that favors L-ascorbic acid over D-isoascorbic acid and that the oxidized form of vitamin C, dehydroascorbic acid, is excluded (5, 34) . Here we explored its molecular mechanisms by testing the hypothesis that the Na ϩ dependence and rheogenicity of SVCT1 arise from coupled transport of two Na ϩ and one L-ascorbic acid per transport cycle and that L-ascorbic acid transport is driven by the electrochemical gradient for Na ϩ . Our approach was to measure radiotracer (L- [ 14 C]ascorbic acid, 22 Na) fluxes and currents in Xenopus oocytes expressing SVCT1 and to model the kinetic mechanisms of SVCT1 with the aid of computer simulation.
MATERIALS AND METHODS

Heterologous expression of human SVCT1 in Xenopus oocytes.
We performed laparotomy and ovariectomy on adult female Xenopus laevis frogs under 2-aminoethylbenzoate methanesulfonate anesthesia (0.1% in 1:1 water-ice, by immersion) following protocols reviewed and approved by the Harvard Area Standing Committee on Animals or the University of Cincinnati Institutional Animal Care and Use Committee. Ovarian tissue was isolated and treated with collagenase A (Roche Diagnostics), and defolliculate oocytes were isolated and stored at 18°C in modified Barths' medium, as described (15) . The pTLNii vector containing the human SVCT1 cDNA (complementary to transcript 1 with sequence accession ID NM_005847) (34) under the SP6 promoter was linearized with SnaBI (New England BioLabs), and RNA was synthesized in vitro with the use of the Ambion mMESSAGE mMACHINE kit and SP6 RNA polymerase according to the manufacturers' protocols. We injected oocytes with Ϸ50 ng of human SVCT1 cRNA and incubated these for 2-4 days before performing voltage-clamp or radiotracer experiments at 22-24°C (except where noted).
Media used for functional assays in oocytes. Functional assays were performed using a standard Na ϩ uptake medium containing (in mM): 100 NaCl, 2 KCl, 1 CaCl 2, 1 MgCl2, and 10 HEPES (pH 7.5 with Tris base). For Na ϩ -free or low-Na ϩ media, NaCl was replaced by equimolar choline chloride (ChoCl).
Voltage-clamp experiments. We used the two-microelectrode voltage clamp (Dagan CA-1B amplifier) to measure currents associated with SVCT1 in oocytes. Microelectrodes (resistance 0.5-5 M⍀) were filled with 3 M KCl. Voltage-clamp experiments comprised two protocols: 1) continuous current recordings were made at a holding potential (V h) of Ϫ50 mV, low-pass filtered at 20 Hz, and digitized at 1 Hz; 2) oocytes were clamped at Vh ϭ Ϫ50 mV, and step changes in membrane potential (Vm) were applied (from ϩ50 to Ϫ150 mV in 20-mV increments), each for a duration of 100 ms, before and after the addition of substrate. Current was low-pass filtered at 500 Hz and digitized at 5 kHz. Steady-state data were obtained by averaging the points over the final 16.7 ms at each V m step. Test solutions were always washed out with substrate-free medium (100 mM ChoCl, pH 7.5) for at least 2 min. Steady-state data from protocols 1 or 2 were fit by a modified Hill relationship (Eq. 1) for which I is the evoked current, I max the derived current maximum, S the concentration of substrate S (Na ϩ or L-ascorbic acid), K 0.5 S the substrate concentration at which current was half-maximal, and nH the Hill coefficient for S.
Currents obtained over the range of temperatures 18 -30°C were fit by an integrated Arrhenius function (Eq. 2), for which Ea is the Arrhenius activation energy, A the y-intercept, R the universal gas constant (1.987 cal ⅐ mol Ϫ1 ⅐ K), T the absolute temperature, and I the current evoked by 500 M L-ascorbic acid in standard Na ϩ medium.
Step changes in Vm using protocol 2 resulted in pre-steady-state currents in oocytes expressing SVCT1. These were isolated from capacitive transient currents (which decayed with half-times of 0.3-0.9 ms) and steady-state currents by the fitted method (9, 15, 21, 22 
Transporter-mediated pre-steady-state currents can be used to estimate transporter density (37) . We estimated the number (per oocyte) of functional units (N T) of the SVCT1 transporter expressed in the plasma membrane using Eq. 4 in which e is the elementary charge (1.6 ϫ 10 Ϫ19 C).
Radiotracer uptake experiments. We determined the Na ϩ -L-ascorbic acid coupling stoichiometry by measuring radiotracer fluxes under voltage clamp (Ϫ50 mV), a method we have described elsewhere for other Na ϩ -coupled transporters (15, 18, 19, 36) . We used L-[1-14 C]ascorbic acid at final specific activity 0.3-3 GBq/mmol and 22 Na at a final specific activity 0.34 MBq/mg (both from Perkin-Elmer Life Sciences). At the end of the 5-min uptake period, oocytes were rinsed with ice-cold ChoCl medium and solubilized with 5% SDS before 14 C or 22 Na content was assayed by liquid scintillation counting. Statistical and regression analysis. Statistical analyses were performed using SigmaStat version 3.5 (Systat Software) with a critical significance level of ␣ ϭ 0.05. We used two-way ANOVA for between-group comparisons. Linear and nonlinear regression analyses using the least-squares method were performed using SigmaStat, and errors presented are the SEs of the estimates. Pre-steady-state current data were fit by Eq. 3 using Clampfit version 9.2 in the pCLAMP software suite (Axon Instruments).
Modeling of SVCT1-mediated pre-steady-state currents. We propose an eight-state model (see Fig. 5 ) to account for our experimental data for SVCT1. In the absence of L-ascorbic acid, SVCT1 exhibits pre-steady-state currents that are sensitive to changes in extracellular Na ϩ concentration. We tested whether transitions between three carrier states, namely the empty carrier at the external face C1 ϭ [C]Ј, or at the internal face C8 ϭ [C]Љ, and the outward-facing Na ϩ -bound configuration C2 ϭ [CNa]Ј, can account for the pre-steady-state currents observed for SVCT1 by computer simulation of the partial reaction. We did not consider the inward-facing Na ϩ -bound configuration C7 ϭ [CNa]Љ since intracellular Na ϩ concentration ([Na ϩ ]) is generally low. Our partial-reaction model is essentially identical to that used to describe the Na ϩ -glucose cotransporters SGLT1 (9, 14, 28) and SGLT3 (formerly pSGLT2) (17) and similar to that used to describe a myo-[H ϩ ]inositol cotransporter (12) . The rate of change in concentration of each carrier state is given by the difference of forward and reverse reactions
in which the reaction step Cx 3 Cy is described by the rate kxy, which comprises its voltage-independent rate constant k xy o ; C1 ϩ C2 ϩ C8 ϭ 1. Thus the effect of membrane potential on Na ϩ binding/dissociation and translocation of the empty carrier is described by the following Eyring-theory reaction rates. We assumed one Na ϩ -binding event (n ϭ 1) and carrier valence (zC) of Ϫ1, based on experimental observations (see Figs. 1G and 4C).
␣ and ␦ are phenomenological coefficients describing the fraction of the membrane electric field sensed by Na ϩ binding/dissociation at the external face (␣Ј) and at the internal face (␣Љ) and by reorientation of the empty carrier (␦). Microscopic reversibility requires that ␣Ј ϩ ␣Љ ϩ ␦ ϭ 1 (13). We did not consider [CNa]Љ (state 7), so ␣Љ ϭ 0.
[Na] o is the extracellular Na ϩ concentration; and ϭ FV/RT where F, R, and T have their usual thermodynamic meanings. We simulated the pre-steady-state current using Berkeley Madonna modeling software, integrating the carrier-state concentration equations (Eqs. 5-7) such that the pre-steady-state current (I t) is given by Eq. 12.
We obtained estimates of the voltage-independent rate constants k 12 o , k 21 o , k 18 o , and k 81 o by simulating It best approximating the compensated pre-steady-state currents observed for SVCT1. Initial carrierstate concentrations were derived using root equations that were simultaneously solved for carrier-state proportions in the case of zero charge movement (i.e., at Ϫ50 mV).
RESULTS
Currents associated with expression of human SVCT1 in
Xenopus oocytes. L-Ascorbic acid (at up to 1 mM in 100 mM NaCl medium) evoked inward currents of up to Ϫ250 nA in Xenopus oocytes expressing human SVCT1 ( Fig. 1) , whereas L-ascorbic acid-evoked currents of only 0 to Ϫ3 nA in control oocytes (Fig. 1A) . The L-ascorbic acid-evoked currents for SVCT1 were rapidly reversible on removal of Na ϩ and L-ascorbic acid ( Fig. 1A ) and were saturable (Fig. 1B) . The half-maximal concentration of L-ascorbic acid (K 0.5 Asc ) in this example was 76 Ϯ 7 M. The mean K 0. 5 Asc determined from seven independent experiments was 72 M (SD 20 M; 95% confidence limits 54 and 91 M). The Hill coefficient for L-ascorbic acid (n H Asc ) was Ϸ1 and did not vary with membrane potential (V m ). The derived maximum current (I max Asc ) varied significantly with V m (Fig. 1C) . The I max Asc /V m relationship was roughly linear between ϩ50 and Ϫ10 mV. I max Asc peaked at between Ϫ30 and Ϫ50 mV and was then reduced at hyperpolarized V m . K 0.5
Asc did not vary with V m at negative potentials (Fig. 1D ). The slight increase in K 0. 5 Asc at positive V m probably arises from the fact that the [Na ϩ ] of 100 mM is subsaturating at positive V m (see below). Therefore, it is likely that SVCT1 binding of Lascorbic acid is voltage independent.
The currents evoked by 100 M L-ascorbic acid varied as a function of Na ϩ concentration (Fig. 1E) . The current-voltage relationship at 100 mM Na ϩ resembled that described for I max Asc /V m , roughly linear between ϩ50 and Ϫ30 mV and peaking at Ϫ50 mV. A decrease in the evoked currents was observed at hyperpolarized potentials (Ϫ70 to Ϫ110 mV). At any given V m , the L-ascorbic acid-evoked current was always greater at higher extracellular Na ϩ concentration ([Na ϩ ] o ) in the range 20 through 100 mM Na ϩ (for clarity, data at 20 mM Na ϩ were not shown). The current-voltage relationship (and the peak current) shifted in the hyperpolarizing direction with decreasing [Na ϩ ] o . Therefore, the L-ascorbic acid-evoked currents are driven by the Na ϩ electrochemical potential gradient.
The reduction of L-ascorbic acid-evoked currents (and I max Asc ) at hyperpolarized potentials (more negative than around Ϫ70 mV) observed for human SVCT1 is more pronounced than what we previously observed for rat SVCT1 (33) . We have observed a similar phenomenon for the H ϩ -coupled peptide transporters PEPT1 (16) and PEPT2 (4). In the case of PEPT1, the inhibition at hyperpolarized potentials was associated with a 10-fold increase in K 0.5 for the dipeptide. We considered that binding of L-ascorbic acid (given its 1Ϫ charge at neutral pH, see Fig. 2D ) to SVCT1 may be hindered at extreme hyperpolarized potentials, but the voltage independence of K max Asc (Fig.  1D) does not support such a conclusion. Alternatively, activation of an additional ion conductance at hyperpolarized potentials may result in reduced net current. If this is the case, however, it is unlikely to involve Cl Ϫ , since the L-ascorbic acid-evoked currents were unaffected by replacement of Cl Ϫ with gluconate (data not shown).
We found that switching from Na ϩ -free to 100 mM Na ϩ medium (in the absence of L-ascorbic acid) evoked larger inward currents in oocytes expressing SVCT1 than in control oocytes (Fig. 1, A and F) . The Na ϩ currents in oocytes expressing SVCT1 were Ϸ13% the magnitude of the currents evoked by 500 M L-ascorbic acid in 100 mM Na ϩ medium. . F: comparison of the Na ϩ uniport (leak) and Na ϩ -L-ascorbic acid cotransport activities of SVCT1. The difference in current between Na ϩ -free medium and 100 mM NaCl medium was taken as a measure of Na ϩ uniport (hatched bars) in oocytes expressing SVCT1 and compared with control oocytes. The current evoked by 500 M L-ascorbic acid in 100 mM NaCl was taken as a measure of Na ϩ -L-ascorbic acid cotransport (filled bars). Two-way ANOVA revealed a significant interaction (P Ͻ 0.001, n ϭ 6 -41/group). G: [Na ϩ ] dependence of the Na ϩ uniport and Na ϩ -L-ascorbic acid cotransport activities of SVCT1. Currents evoked by 100 M L-ascorbic acid (circles) were activated by Na ϩ ; the data were fit by Eq. 1, yielding n H Na ϭ 1.9 Ϯ 0.3, K 0.5 Na ϭ 50 Ϯ 8 M, and I max Na ϭ Ϫ91 Ϯ 12 nA (r 2 ϭ 0.991; P Ͻ 0.001). For Na ϩ uniport (triangles), n H Na ϭ 1.2 Ϯ 0.1, K 0.5 Na ϭ 103 Ϯ 27 M, and I max Na ϭ Ϫ57 Ϯ 9 nA (r 2 ϭ 0.999; P Ͻ 0.001). H: temperature dependence of the Na ϩ -L-ascorbic acid cotransport activity of SVCT1. The currents evoked by 1 mM L-ascorbic acid at 100 mM NaCl in a single oocyte expressing human SVCT1 over the temperature range 18 -30°C were fit by Eq. 2. The predicted Arrhenius activation energy (Ea) was 23.4 Ϯ 0.9 kcal/mol (lnA ϭ Ϫ43 Ϯ 1 nA; r 2 ϭ 0.993; P Ͻ 0.001).
Such Na ϩ currents are consistent with SVCT1 mediating a modest Na ϩ uniport ("internal leak") pathway in the absence of L-ascorbic acid, a phenomenon that is common among mammalian Na ϩ -coupled nutrient transporters, including the Na ϩ -glucose cotransporter SGLT1 (18) . Currents evoked by 100 M L-ascorbic acid in an oocyte expressing SVCT1 demonstrated a sigmoidal dependence on Na ϩ concentration, with half-maximal Na ϩ concentration (K 0.5 Na ) of Ϸ50 mM and Hill coefficient (n H Na ) for Na ϩ of Ϸ2 (Fig. 1G) , suggesting that two Na ϩ activate SVCT1-mediated L-ascorbic acid transport per cycle. In contrast, the Na ϩ uniport pathway (n H Na Ϸ 1) appears to only involve the binding of one Na ϩ and appears to require much higher Na ϩ concentrations for saturation. K 0.5 Na for Na ϩ -L-ascorbic acid cotransport varied with membrane potential (data not shown): in the same experiment shown in Fig. 1E , we estimated K 0.5 Na to range from 46 mM at Ϫ110 mV to well over 100 mM at Ϫ10 mV and at positive V m .
In summary, the currents evoked by Na ϩ and L-ascorbic acid in oocytes expressing SVCT1 support the conclusions that: 1) SVCT1 is a high-affinity L-ascorbic acid transporter (K 0.5
Asc Ϸ 70 M), 2) SVCT1-mediated L-ascorbic acid transport is driven by the Na ϩ electrochemical potential gradient, 3) SVCT1 also mediates Na ϩ uniport in the absence of Lascorbic acid, and 4) two Na ϩ are required to bind to SVCT1 to activate L-ascorbic acid transport, whereas only one Na ϩ per transport cycle participates in Na ϩ uniport. Temperature dependence of the Na ϩ -L-ascorbic acid cotransport activity of SVCT1. The SVCT1-mediated L-ascorbic acid-evoked currents were highly temperature dependent and increased from Ϫ20 nA at Ϸ18°C to Ϫ98 nA at Ϸ30°C. The predicted Arrhenius activation energy (E a ) was Ϸ23 kcal/mol (Fig. 1H) . The corresponding temperature coefficient Q 10 (the factor by which activity was increased for every 10°increase in temperature) over this temperature range was 4.6 Ϯ 0.2. These data support the "carrier" model of transport in which Na ϩ -Lascorbic acid transport comprises a series of ligand-induced conformational changes. In contrast, channels are expected to comprise fewer conformational changes and therefore be less temperature dependent. Na ϩ -L-ascorbic acid coupling stoichiometry of SVCT1. We determined Na ϩ -L-ascorbic acid coupling stoichiometry of SVCT1 by measuring 22 Na ϩ and L-[ 14 C]ascorbic acid fluxes in individual oocytes under voltage clamp and relating the fluxes to net charge translocation (Fig. 2) . Two Na ϩ were transported per net positive charge, and the net positive charge influx was equivalent to the influx of L-ascorbic acid. Because L-ascorbic acid bears a charge of 1Ϫ at pH 7.5, these data demonstrate that the coupling ratio is two Na ϩ per one L-ascorbic acid under the conditions described. The Hill coefficient (n H Na ) for Na ϩ of Ϸ2 (Fig. 1G ) therefore indicates that there is strong cooperativity between the two Na ϩ -binding sites involved in cotransport.
Ordered binding and simultaneous transport of Na ϩ and L-ascorbic acid by SVCT1. We examined the order of substrate binding to SVCT1 and the cotransport mechanism by determining the saturation kinetics parameters [K 0.5 and maximum current (I max )] for both Na ϩ and L-ascorbic acid as a function of the cosubstrate concentration (Fig. 3) . Our data indicate that Na ϩ and L-ascorbic acid are translocated simultaneously, since K 0.5 for each substrate was at its lowest in the presence of Fig. 2 . Na ϩ -L-ascorbic acid coupling stoichiometry for SVCT1. Radiotracer uptake was measured under voltage clamp [holding potential (Vh) ϭ Ϫ50 mV] in individual oocytes expressing SVCT1. L-Ascorbic acid-evoked currents were integrated with time to obtain charge and converted to a molar equivalent (Q Asc in pmol) using the Faraday constant (9.65 ϫ 10 4 C/mol). A: typical current record for an individual oocyte superfused initially with 50 mM unlabeled Na ϩ and then 50 mM 22 Na ϩ plus 1 mM L-ascorbic acid (L-Asc) for the period shown by the filled bar. L-Ascorbic acid-dependent charge (Q Asc ) was calculated as the gray shaded area. B: comparison of Q Asc (gray bar) and 22 Na ϩ accumulation (filled bar) over 5 min in oocytes expressing SVCT1 (mean Ϯ SD, n ϭ 6) superfused with 50 mM higher concentrations of the cosubstrate (11, 17, 19, 31) . In contrast, for a consecutive carrier model, the K 0.5 values are expected to rise as cosubstrate concentration is increased.
The I max for Na ϩ (I max Na ) was dependent on the L-ascorbic acid concentration, i.e., L-ascorbic acid concentration imposed a limitation on the maximal rate of transport even when Na ϩ was saturating. This observation rules out the possibility that SVCT1 first binds L-ascorbic acid. Therefore, one or both Na ϩ -binding events must precede L-ascorbic acid binding, a conclusion that is supported by our observations that SVCT1 can mediate Na ϩ uniport (see Fig. 1 ) and Na ϩ -sensitive presteady-state currents (see Fig. 4 ), each indicating that SVCT1 can bind Na ϩ in the absence of L-ascorbic acid. Moreover, we found that I max Asc was dependent on the Na ϩ concentration (Fig.  3D) , indicating that the second Na ϩ must bind after the ascorbate-binding step. In contrast, considering a carrier model in dynamic equilibrium, we should expect that saturating L-ascorbic acid would always drive the transporter at its maximal rate were L-ascorbic acid bound last (11, 17, 19, 31) . Our data are not consistent with a random-binding model in which case I max for either substrate would be independent of the cosubstrate concentration.
We conclude from these data that the order of substrate binding by SVCT1 is Na ϩ , L-ascorbic acid, Na ϩ , followed by their simultaneous translocation (see Fig. 5 ). Our conclusion is further supported by the observation that the Na ϩ Hill coefficient (n H Na ) was Ϸ2 in the case of Na ϩ -L-ascorbic acid cotransport but only Ϸ1 in the case of Na ϩ uniport (Fig. 1F) . Pre-steady-state currents associated with SVCT1. We observed pre-steady-state currents following step changes in V m in oocytes expressing SVCT1 (but not in control oocytes) in the absence of L-ascorbic acid (Fig. 4) . Pre-steady-state currents associated with SVCT1 decayed exponentially with time constants () of 3-15 ms (Fig. 4B) and were essentially abolished in the presence of saturating L-ascorbic acid (data not shown). Fitting of the /V m relationship using a Gaussian function revealed a maximum time constant ( max ) of Ϸ15 ms at membrane potential (V max ) approximately equal to Ϫ18 mV. Pre-steady-state currents were integrated with time to obtain charge (Q); the Q/V m relationship at 100 mM Na ϩ could be described by a single Boltzmann function with Q max of Ϸ25 nC and midpoint (V 0.5 ) approximately equal to Ϫ9 mV (Fig.  4C) . The apparent valence (z) of the movable charge was approximately equal to Ϫ1. Using Eq. 4, we estimated N T , the number of functional SVCT1 units in the plasma membrane, to be 1.7 ϫ 10 11 /oocyte. We also estimated turnover rates of the transport cycle as a function of V m using the relation ϪI/Q max taking I to be the current evoked by 1 mM (saturating) L-ascorbic acid. The maximal turnover rate for this oocyte was 9.7 Ϯ 0.2 s Ϫ1 at Ϫ50 mV, dropping to Ϸ6 s Ϫ1 at Ϫ110 and ϩ10 mV. The predominant effect of lowering the [Na ϩ ] was to shift the Q/V m relationships to more hyperpolarized potentials without a significant effect on maximal charge (Fig. 4, C and E) since Q max did not vary significantly with [Na ϩ ] (P ϭ 0.41), whereas V 0.5 shifted by 77 mV per 10-fold change in Na ϩ concentration (P Ͻ 0.001).
DISCUSSION
Molecular mechanisms of SVCT1. We have characterized the functional properties and kinetic mechanisms of the human L-ascorbic acid transporter SVCT1 heterologously expressed in Xenopus oocytes. L-Ascorbic acid transport was saturable (K 0.5 Ϸ 70 M), temperature dependent (Q 10 Ϸ 5), and energized by the Na ϩ electrochemical potential gradient. We obtained a Na ϩ -L-ascorbic acid (1Ϫ) coupling ratio of 2:1 from simultaneous measurement of currents and fluxes in individual oocytes at pH 7.5. The flux ratio is unlikely to differ within the environment of the acidic microclimate of the intestinal brush border (pH Ϸ 6; see Ref. 24) or the renal proximal tubule (luminal pH Ϸ 7), since the ascorbate is still charged 1Ϫ under these conditions (Fig. 2D) ; however, a modest drop in L-ascorbic acid transport activity is observed for SVCT1 at lower pH (33, 34) . The Hill coefficient (n H ) for Na ϩ activation of L-ascorbic acid-evoked currents was Ϸ2, indicating a high degree of cooperativity between the two Na ϩ -binding events. L-Ascorbic acid and Na ϩ saturation kinetics as a function of the cosubstrate concentration revealed a simultaneous transport mechanism in which binding is ordered Na ϩ , L-ascorbic acid, Na ϩ (Fig. 5) . This same binding sequence was recently proposed for a second SVCT isoform, human SVCT2 (7). However, in the latter study, the evidence cited in support of this conclusion is evidence, rather, for a simultaneous transport mechanism, and V max data provided elsewhere in that paper (Fig. 3, C and D (1, 9, 14, 17, 19, 27) or H ϩ -coupled (8, 12, 16, 21, 22, 25) solute transporters. The results of model simulation have led investigators to attribute pre-steady-state currents to two steps in the transport cycle, namely reorientation of the empty charged carrier and binding/dissociation of the driving ion partway within the plane of the membrane electric field (and in some cases also to the binding/dissociation of the ion at the internal face).
We simulated transitions between three states in our model for SVCT1 (Fig. 5) : the empty carrier configurations at the internal face (C 8 ϭ [C]Љ) and the external face (C 1 ϭ [C]Ј) and the Na ϩ -bound outward configuration (C 2 ϭ [CNa]Ј). Presteady-state currents associated with SVCT1 were adequately described by this three-state partial-reaction model using the rate constants and phenomenological coefficients (␣Ј and ␦) given in the legend to Fig. 5 . Our model closely predicted the /V m and Q/V m relationships (Fig. 4, B-D) at 100 mM Na ϩ . The model closely accounted for the shift in V 0.5 to more negative potentials, without significant effect on Q max , observed when [Na ϩ ] o was reduced (Fig. 4, C-E) . That ␣Ј was much greater than ␦ (␣Ј ϭ 0.83) indicates that most of the charge transfer arises from an ion-well effect of Na ϩ binding partway within the membrane electric field. In contrast, a simulation (data not shown) in which we set ␣Ј Ͻ ␦ (␣Ј ϭ 0.32) closely predicted the /V m and Q/V m relationships at 100 mM Na ϩ but underestimated the Na ϩ -dependent shift in V 0.5 (only Ϫ27 mV/decade) and predicted instead a one-sixth reduction in Q max between 100 and 5 mM Na ϩ . Q max effects of the driving-ion concentration were observed for the Na ϩ -glucose cotransporter SGLT1 (14) and the H ϩ -peptide cotransporter PEPT1 (16) and were accounted for by models in which ␣Ј Ͻ ␦ (␣Ј Ϸ 0.3).
Our model predicted that most of the SVCT1 carriers are in the Na Turnover rates of the transport cycle at 100 mM Na ϩ ranged from 6 to 10 s Ϫ1 , peaking at Ϫ50 mV. From the comparison of turnover rates with the reciprocals of (Fig.  4B) , we conclude that neither the reorientation of the empty carrier nor Na ϩ binding is likely to be a rate-limiting step in the transport cycle at any V m . Model simulation confirms this Fig. 5 . Model describing the operation of the Na ϩ -L-ascorbic acid cotransporter SVCT1. The rheogenicity and transport properties of SVCT1 are explained by an 8-state model of SVCT1 in which the empty carrier bears net charge of 1Ϫ and substrate binding is ordered Na ϩ , L-ascorbic acid (1Ϫ) (Asc 1Ϫ ), Na ϩ . Thus translocation of the fully loaded carrier is electroneutral. (The order of intracellular substrate dissociation is assumed.) Each carrier state is identified by a number (1) (2) (3) (4) (5) (6) (7) (8) and by a prime denoting that the carrier is at the external face of the membrane or double prime indicating the internal face. A Na ϩ uniport pathway or "internal leak," also electroneutral (n H Na ϭ 1), is shown as step 2 3 7. Model simulation of transitions between states 8, 1, and 2 can account for the pre-steady-state currents observed for SVCT1 in the absence of L-ascorbic acid (Fig. 4) . The partial-reaction scheme (indicated by the shaded area) is described by four rates (k12, k21, k18, and k81) for which kxy represents the reaction step x 3 y. These four steps comprise translocation of the empty charged carrier and binding/dissociation of only the first Na ϩ at the extracellular face. Each rate kxy is defined by its voltage-independent rate constant k xy o , the electrical potential , and (in the case of k12) [Na ϩ ], as well as the phenomenological coefficients ␣Ј and ␦, which describe the fraction of the membrane electric field sensed by Na ϩ binding/dissociation at the external face (␣Ј) and by reorientation of the empty carrier (␦). We did not consider [CNa]Љ (state 7) in the partial reaction since intracellular [Na ϩ ] is generally low. Thus we set ␣Љ (the fraction of the electric field sensed by Na ϩ binding/dissociation at the internal face) at 0, and microscopic reversibility requires that ␣Ј ϩ ␣Љ ϩ ␦ ϭ 1 (13) . ϭ FV/RT where F, R, and T have their usual thermodynamic meanings. Model simulations (Fig. 4, D and  F ; also shown as broken lines alongside observed data in Fig. 4, B, C, and E) 
Conclusions
In conclusion, we have demonstrated that SVCT1 is a voltage-dependent and rheogenic two Na ϩ -one L-ascorbic acid (1Ϫ) cotransporter (symporter) with high affinity for Lascorbic acid (K 0.5 Ϸ 70 M). SVCT1 exhibited marked temperature dependence (Q 10 Ϸ 5). Our data fit an ordered simultaneous transport model with binding sequence Na ϩ , L-ascorbic acid, Na ϩ . Model simulation predicts that the rheogenicity of SVCT1 arises predominantly (83%) from an ionwell effect of Na ϩ binding partway within the membrane electric field and, to a much lesser extent (17%), also from the translocation of the empty charged (1Ϫ) carrier (i.e., ␣Ј Ͼ ␦). Neither of these steps limits the rate of Na ϩ -L-ascorbic acid cotransport. Translocation of the fully loaded carrier (symport) and the internal Na ϩ leak (Na ϩ uniport) pathway are proposed to be electroneutral steps. Our kinetic model provides a framework for investigating the impact of specific mutations and polymorphisms in the SLC23A1 gene coding for SVCT1. It is anticipated that this work will help to elucidate the contribution of SVCT1 to vitamin C metabolism in health and disease.
